Aetna Has About 70% of Medicare Advantage Members in Four-Star-or-Better 2027 Plans, CVS Health Says
By Katherine Hamilton
CVS Health's health-insurance company Aetna said that more 69% of its Medicare Advantage members are in 2027 plans rated four stars or higher by the government.
The Centers for Medicare & Medicaid Services evaluates insurance plans based on a five-star rating system every year.
Aetna received five stars for its care for older adults medication review and 4.03 stars for its care for older adults functional status assessment, CVS Health said.
On plan all-cause readmissions, which tracks the percentage of patient hospital stays followed by an unplanned readmission, received 4.77 stars, the company said.
Aetna has above four-star ratings for its rate of complaints about the drug plan, customer service and rating of healthcare quality, CVS Health said.
Shares of the company slipped 2.7%, to $85.47, after hours Thursday after closing about flat, at $87.80.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
October 08, 2026 18:49 ET (22:49 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for October
The 10 Best Companies to Invest in Now
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
3 Stocks to Invest In With More Room to Run
United States